Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

TLV/IMED stock hub

TLV/IMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/IMEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.5M

Tel Aviv Stock Exchange

Market data

Price

Recent price action with selectable time range.

TLV/IMEDTLV/IMED

—

Loading chart…

In the news

Latest news · TLV/IMED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-2.5

P25 n/aP50 n/aP75 n/a

ROIC-3.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/IMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

USD

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	80
Employees Change	10%
Employees Change Percent	14.29
Enterprise value	ILA -4.7M
Exchange	Tel Aviv Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Health Information Services
Isin	IL0011712309
Last refreshed	2026-05-10
Market cap	ILA 4.5M
Price	ILA 111
Price currency	ILA
Rev Per Employee	9,006.1x
Sector	Healthcare
Sic	7370
Symbol	tlv/IMED
Website	https://www.infinitymedical.co.il/

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.69%
EV Earnings	7.71x
P/B ratio	0.18x
P/S ratio	6.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-188.5%
Gross margin	100%
Gross Profit	ILA 720,488
Gross Profit Growth	-72.37%
Net Income	ILA -612,096
Net Income Growth Years	2%
Pretax Margin	-84.96%
Profit Margin	-84.96%
Profit Per Employee	ILA -7,651
ROA	-3.39
Roa5y	-5.67
ROCE	-5.42
ROE	-2.5
Roe5y	-9.2
ROIC	-3.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-21.71%
Cagr3y	31.92%
Cagr5y	-19.38%
EPS Growth Years	2
Revenue Growth	451.22x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.03
Assets	ILA 25.6M
Cash	ILA 9.2M
Current Assets	ILA 8.4M
Current Liabilities	ILA 542,487
Equity	ILA 25M
Liabilities	ILA 596,156
Long Term Assets	ILA 17.2M
Long Term Liabilities	ILA 53,669
Net Cash	ILA 9.2M
Net Cash By Market Cap	ILA 206
Net Cash Growth	226.13%
Net Debt Equity	ILA -0.37
Tangible Book Value	ILA 25M
Tangible Book Value Per Share	ILA 6.21
WACC	5.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.47
Net Working Capital	ILA -564,276
Quick ratio	15.47
Working Capital	ILA 8.6M
Working Capital Turnover	ILA 0.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-21.7%
200-day SMA	118.2
3Y total return	129.61%
50-day SMA	116.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-65.94%
All Time High	1,180
All Time High Change	-90.61%
All Time High Date	2021-01-05
All Time Low	52.7
All Time Low Change	110.25%
All Time Low Date	2025-03-31
ATR	4.29
Beta	0.25
Beta1y	0.33
Beta2y	-0.48
Ch YTD	-9.11
High	110.8
High52	192
High52 Date	2025-05-13
High52ch	-42.29%
Low	110.8
Low52	101
Low52 Date	2025-05-08
Low52ch	9.7%
Ma50ch	-5.11%
Price vs 200-day SMA	-6.3%
RSI	42.46
RSI Monthly	42.4
RSI Weekly	0
Sharpe ratio	1.44x
Sortino ratio	4.21
Total Return	1.76%
Tr YTD	-9.11
Tr1m	-1.95%
Tr1w	-2.81%
Tr3m	-14.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -1.4M
Operating margin	-188.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Insiders	80.51%
Shares Institutions	19.5%
Shares Out	4,035,000
Shares Qo Q	6.39%
Shares Yo Y	-1.76%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	16,439.2x
Bv Per Share	6.21
Ch1m	-1.95
Ch1w	-2.81
Ch1y	-21.7
Ch3m	-14.44
Ch3y	-7.9
Ch5y	-86.34
Ch6m	-14.57
Change	0%
Change From Open	0
Close	110.8
Days Gap	0
Dollar Volume	194,786.4
Earnings Date	2026-08-21
EBIT	ILA -1.4M
EPS	ILA -0.15
F Score	0
Financing CF	1,632,256
Fiscal Year End	December
Founded	2,020
Investing CF	5,824,476
Is Primary Listing	1
Last Earnings Date	2025-11-26
Last Report Date	2025-12-31
Ma150	122.9
Ma150ch	-9.87%
Ma20	116.8
Ma20ch	-5.15%
Net CF	6,372,812
Next Earnings Date	2026-08-21
Open	110.8
Price Date	2026-05-06
Ptbv Ratio	0.18
Relative Volume	0.11x
Revenue	720,488x
Tr6m	-14.57%
Volume	1,758
Z Score	4.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLV/IMED pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/IMED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/IMED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.5%

Share of float held by funds and institutions

Insider ownership

+80.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.8%

Negative means the company is buying back shares.

Technical

TLV/IMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.5

Neutral momentum band

Price vs 200-day MA

-6.3%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

1.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/IMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/IMED stock rating?

tlv/IMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/IMED analysis?

The full report lives at /stocks/tlv/IMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/IMED?

The latest report frames tlv/IMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/IMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.